loader2
Partner With Us NRI

Company details

120.00
120.00
77.90
189.50
6M Return -4.12%
1Y Return 24.74%
Mkt Cap.(Cr) 7.50
Volume 19
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 19

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: -2.66 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 30,916.98 -48,103.23
LAST 3M 78,536.21 -48,038.81
LAST 6M 142,324.16 -197,260.78
LAST 12M 202,697.52 -165,959.31
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
23.39
51.63%
-39.4224
39.04%
-11.13%
Description
  • Muller & Phipps (India) Ltd(MPIL), promoted by Muller & Phipps International Corp. of USA is engaged in the business of trading in Toilet Preparations and Medicated Preparations. Development Holding Asia Ltd holds 51.6 % stake in the MPIL. The company incorporated in Calcutta in Oct.`17.It turned public limited in Nov.`73. The company owned the one of the popular Talcum Powder brand `Cuticura`. Chalayil Group, a leading south based FMCG company and owner of Medimix brand has acquired `Cuticura` brand from the company. The Company acts as distributors for both foreign and domestic personal care companies. MPIL acts as distributor for (i) Christine Hoden (India) Pvt. Ltd., for their sanilary towels, (ii) Cooper Laboratories International Inc, for their Knox medicinal specialties, (iii) Bombay Forgings Pvt. Ltd., for their "Vita" tooth brushes and (iv) Hamdard Laboratories (India) for their medicinal products. The Company also sells Shellox with Vapona (insecticide) purchased by it in bulk from national Organic Chemical Industries, Ltd. Further the company inked an distribution arrangement for Black Rose range of products and Dupen Laboratories Oral Health Care and Generic Drugs in FY2002-03. Muller & Phipps Agencies Ltd. (Formerly Chakosheela Trading & Agencies, Ltd.) and Muller & Phipps (Industrial Services) Ltd., are subsidiaries of the Company. After the issue of shares to the public during Dec.`73, the holding of Muller & Phipps International Corporation, USA in the Company was reduced from 100% to 40%. For distribution & marketing their entire range of products including Cuticura the company formulated a strategic alliance with Dorcas Market Makers Ltd.

Read More

Registered Address

204 Madhva Comm Premises, C-4 Bandra Kurla complex Bandr, Mumbai, Maharashtra, 400051

Tel : 91-22-26591191
Email : mnpco:mulphico.c.in
Website : http://www.mulphico.co.in

Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 501477
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE003F01015

ICICIdirect Muller & Phipps (India) Ltd FAQ

You can buy Muller & Phipps (India) Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Muller & Phipps (India) Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 17, 2022 04:01 PM the closing price of Muller & Phipps (India) Ltd was ₹ 120.00.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 17, 2022 04:01 PM, the market cap of Muller & Phipps (India) Ltd stood at ₹ 7.50.
The latest PE ratio of Muller & Phipps (India) Ltd as of May 17, 2022 04:01 PM is 23.39
The latest PB ratio of Muller & Phipps (India) Ltd as of May 17, 2022 04:01 PM is -0.33
The 52-week high of Muller & Phipps (India) Ltd is ₹ 189.50 while the 52-week low is ₹ 77.90 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE